Investor's Champion share news, analysis and insight

Make your money go further for just 25p per day

PREMIUM
AIM IHT

Survival of an innovator | Veterinary reassurance | Broker reluctance

24/07/2025 · Big Technologies (BIG)  · CVS Group (CVSG)  · Netcall (NET)  · Nexteq (NXQ)  · Portmeirion Group (PMP)  · Surface Transforms (SCE)  · Yu Group (YU/) 

AIM AIM Inheritance Tax potential UK

Brake discs

A manufacturer of automative components sees its shares bounce as it gets to grips with production issues. Elsewhere, a large veterinary services group is growing fast down under as the UK market remains under the scrutiny of a CMA review, while the stock market places little value on the operating businesses of a cash rich technology solutions group. Read on here for more on this and plenty of other positive news from AIM.


CVS: UK on pause (or paws!), Australia going strong

CVS Group (AIM:CVSG), the veterinary services group with a growing presence in Australia, announced an in-line trading update for its financial year to 30 June 2025.

Revenue from continuing operations grew 5.4% to £673.2m with like-for-like sales (excluding the impact of acquisitions) increasing by 0.2%. Growth was impacted by softer market conditions in the UK.

The Group expects to report fairy tale adjusted…

Continue reading our content…

Gain access to all our excellent content for just £90 per year, that’s just 25p per day for financial freedom.
  • Unlimited access to our market-beating portfolios
  • In-depth coverage of many of the world’s great companies
  • Unique insights from our top research team
Register FREE for access to limited content.
  • Company and markets insights
  • Sponsored content
  • Podcasts

DON'T MISS OUT!

Get top investment ideas to help safeguard and grow your wealth.

Invaluable insight from the exciting world of smaller companies.

REGISTER FREE

DON'T MISS OUT ON OUR PREMIUM CONTENT

Become a champion investor for just £90 a year. Benefit from our high performing portfolios:

START FREE TRIAL

More on Big Technologies

Survival of an innovator | Veterinary reassurance | Broker reluctance

Litigation issues | Modest valuation | Publishing doubts

Bonkers Bargain climbs | Murray mayhem | Cancellation crash

Gold winner | Entrepreneurial success | CEO suspension

More on CVS Group

Survival of an innovator | Veterinary reassurance | Broker reluctance

CMA reflects | Another Main Market mover | Bonkers Bargain cheer

CMA relief | Software success | Offers galore

Cladding delivers | CEO clears the decks | Nice price

More on Netcall

Survival of an innovator | Veterinary reassurance | Broker reluctance

15% dividend yield - too good to be true?

Game improvements | Ever reliable | Mortgage optimism

Angling for growth | Hostel delights | Unusual software

More on Nexteq

Survival of an innovator | Veterinary reassurance | Broker reluctance

Gold winner | Entrepreneurial success | CEO suspension

7% dividend yield | Hostel happiness | Another AIM leaver

Deep breath | Unanswered questions| Cash builds

More on Portmeirion Group

Survival of an innovator | Veterinary reassurance | Broker reluctance

Mandate loss | Korean woes | AI investment

Energetic returns | Recovery play

Downgrades | Bargains | Interest rate winners

More on Surface Transforms

Survival of an innovator | Veterinary reassurance | Broker reluctance

Will it survive? | Largest contract to date | Stunning results

AIM takeovers | Automotive excellence and struggles

Delightful results and special dividend | Bonkers Bargain impresses

More on Yu Group

Survival of an innovator | Veterinary reassurance | Broker reluctance

Gold winner | Entrepreneurial success | CEO suspension

Stonking Small Cap strength | Big dividend payer | Energy growth

Episode 35 of the Investor’s Champion Podcast

Sign-up to our free email updates

SIGN UP

Sign-up to our free email updates

SIGN UP